
CPHI & PMEC China 2026
06/2026 – 06/2026
Hainan Poly Pharm is a leading public generic manufacturer in China, focused on injectables, oral solid formulations and prefilled syringes. Its injectable facility has been inspected and approved by the US FDA, EDQM, WHO and China's NMPA, while its oral formulation facility has been inspected and approved by EDQM, with a new oral formulation facility expected to pass EDQM and US FDA inspection, and expertise in cGMP system maintenance and high-barrier formulation development.

댓글이 없습니다.
평가 & 댓글 남기기